The global Polyglycolic Acid Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Form (Fibers, Films, Others), By End-User (Medical, Oil & Gas, Packaging, Others).
Polyglycolic acid (PGA) is a biodegradable polymer derived from glycolic acid monomers, widely used in medical, pharmaceutical, and packaging industries for its biocompatibility, mechanical strength, and rapid degradation properties. In 2024, the market for polyglycolic acid s to expand as industries seek sustainable and biodegradable alternatives to conventional plastics and materials for various applications. PGA offers advantages such as high tensile strength, stiffness, and absorption rate, making it suitable for medical sutures, implants, drug delivery systems, and tissue engineering scaffolds. In pharmaceutical packaging, PGA is used in films, coatings, and capsules for its moisture barrier properties, oxygen permeability, and biodegradability. PGA polymers can be processed using techniques such as extrusion, injection molding, and solvent casting to produce a wide range of products with tailored mechanical properties and degradation rates. The demand for polyglycolic acid is driven by factors such as the growth of healthcare and pharmaceutical industries, increasing demand for biodegradable and implantable medical devices, and the regulatory push towards reducing plastic waste and environmental pollution. Market trends include the development of bio-based and renewable polyglycolic acid feedstocks, the optimization of polymer processing technologies for improved efficiency and scalability, and the integration of advanced fabrication and surface modification techniques for enhanced functionality and performance.
The market report analyses the leading companies in the industry including Advanced Medical Solutions Group PLC, BASF SE, BMG Inc, Boen Healthcare Co. Ltd, China Petrochemical Corp, Danhua Chemical Technology Co. Ltd, DuPont de Nemours Inc, Evonik Industries AG, Hitachi Ltd, Huizhou Foryou Medical Devices Co. Ltd, Kureha Corp, Merck Group, Meta Biomed Co. Ltd, Orion Sutures India Pvt. Ltd, Samyang Biopharm Corp, Shanghai Pujing Chemical Technology Co. Ltd, Shenzhen Polymtek Biomaterial Co. Ltd, SK Chemicals Co. Ltd, Teleflex Inc, The Chemours Company, Toray Industries Inc, Unisur Lifecare Pvt. Ltd, and others.
One prominent trend in the polyglycolic acid market is the growing demand for biodegradable and sustainable materials. Polyglycolic acid (PGA), a biopolymer derived from renewable resources such as sugarcane or corn starch, is gaining traction as an eco-friendly alternative to traditional petroleum-based plastics. This trend is driven by increasing environmental concerns, regulatory pressures to reduce plastic waste, and growing consumer awareness of sustainability issues. As industries seek to adopt more sustainable packaging solutions, biomedical materials, and other applications, the demand for PGA is expected to continue rising.
A significant driver propelling the polyglycolic acid market forward is the expansion of biomedical and pharmaceutical industries. PGA, with its biocompatibility, biodegradability, and mechanical properties, is widely used in medical applications such as sutures, tissue engineering scaffolds, and drug delivery systems. This driver is fueled by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. As the demand for biodegradable and resorbable materials in healthcare continues to grow, the demand for PGA as a key biomaterial is expected to increase.
An enticing opportunity within the polyglycolic acid market lies in penetrating food packaging applications. PGA, with its barrier properties, flexibility, and biodegradability, offers significant advantages for use in food packaging films, trays, and containers. The opportunity arises from the increasing demand for sustainable packaging solutions in the food and beverage industry, driven by consumer preferences for eco-friendly products and regulatory initiatives to reduce plastic waste. By developing specialized PGA formulations optimized for food contact applications, companies can capitalize on the growing market for biodegradable packaging materials. Collaborating with food manufacturers, packaging converters, and regulatory agencies to develop innovative packaging solutions that meet performance, safety, and regulatory requirements can further drive market penetration and growth in this segment.
Fibers emerge as the largest segment in the Polyglycolic Acid (PGA) market due to their extensive use in various industries and applications. Polyglycolic Acid fibers offer exceptional properties such as high tensile strength, biodegradability, and compatibility with a wide range of processing techniques, making them ideal for diverse applications. In the medical sector, PGA fibers are widely utilized in absorbable surgical sutures due to their biocompatibility and ability to degrade within the body over time. Additionally, PGA fibers find applications in the production of medical implants, tissue engineering scaffolds, and drug delivery systems. In the industrial sector, PGA fibers are used in geotextiles, filtration media, and reinforcement materials due to their high strength and durability. With the growing emphasis on sustainability and eco-friendly materials, the demand for PGA fibers is on the rise across various industries, further solidifying their position as the largest segment in the Polyglycolic Acid market.
The Medical segment is the fastest-growing segment in the Polyglycolic Acid (PGA) market due to increasing demand and diverse applications in the healthcare sector. Polyglycolic Acid exhibits biodegradability, biocompatibility, and excellent mechanical properties, making it highly suitable for medical applications. PGA is extensively used in the production of absorbable surgical sutures, where its biodegradable nature eliminates the need for suture removal, reducing patient discomfort and risk of infection. Additionally, PGA is utilized in the manufacture of medical implants, tissue engineering scaffolds, and drug delivery systems, where its biocompatibility and controlled degradation properties offer significant advantages. The growing prevalence of chronic diseases, rising geriatric population, and increasing healthcare expenditure drive the demand for advanced medical materials like PGA. Furthermore, ongoing research and development initiatives aimed at enhancing the performance and versatility of PGA-based medical products contribute to the segment's rapid growth in the Polyglycolic Acid market. Hence, propelled by its unique properties and expanding applications in the healthcare industry, the Medical segment is poised for significant growth in the coming years.
By Form
Fibers
Films
Others
By End-User
Medical
Oil & Gas
Packaging
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Advanced Medical Solutions Group PLC
BASF SE
BMG Inc
Boen Healthcare Co. Ltd
China Petrochemical Corp
Danhua Chemical Technology Co. Ltd
DuPont de Nemours Inc
Evonik Industries AG
Hitachi Ltd
Huizhou Foryou Medical Devices Co. Ltd
Kureha Corp
Merck Group
Meta Biomed Co. Ltd
Orion Sutures India Pvt. Ltd
Samyang Biopharm Corp
Shanghai Pujing Chemical Technology Co. Ltd
Shenzhen Polymtek Biomaterial Co. Ltd
SK Chemicals Co. Ltd
Teleflex Inc
The Chemours Company
Toray Industries Inc
Unisur Lifecare Pvt. Ltd
*- List Not Exhaustive
TABLE OF CONTENTS
1 Introduction to 2024 Polyglycolic Acid Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Polyglycolic Acid Market Size Outlook, $ Million, 2021 to 2032
3.2 Polyglycolic Acid Market Outlook by Type, $ Million, 2021 to 2032
3.3 Polyglycolic Acid Market Outlook by Product, $ Million, 2021 to 2032
3.4 Polyglycolic Acid Market Outlook by Application, $ Million, 2021 to 2032
3.5 Polyglycolic Acid Market Outlook by Key Countries, $ Million, 2021 to 2032
4 Market Dynamics
4.1 Key Driving Forces of Polyglycolic Acid Industry
4.2 Key Market Trends in Polyglycolic Acid Industry
4.3 Potential Opportunities in Polyglycolic Acid Industry
4.4 Key Challenges in Polyglycolic Acid Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Polyglycolic Acid Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Polyglycolic Acid Market Outlook by Segments
7.1 Polyglycolic Acid Market Outlook by Segments, $ Million, 2021- 2032
By Form
Fibers
Films
Others
By End-User
Medical
Oil & Gas
Packaging
Others
8 North America Polyglycolic Acid Market Analysis and Outlook To 2032
8.1 Introduction to North America Polyglycolic Acid Markets in 2024
8.2 North America Polyglycolic Acid Market Size Outlook by Country, 2021-2032
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Polyglycolic Acid Market size Outlook by Segments, 2021-2032
By Form
Fibers
Films
Others
By End-User
Medical
Oil & Gas
Packaging
Others
9 Europe Polyglycolic Acid Market Analysis and Outlook To 2032
9.1 Introduction to Europe Polyglycolic Acid Markets in 2024
9.2 Europe Polyglycolic Acid Market Size Outlook by Country, 2021-2032
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Polyglycolic Acid Market Size Outlook by Segments, 2021-2032
By Form
Fibers
Films
Others
By End-User
Medical
Oil & Gas
Packaging
Others
10 Asia Pacific Polyglycolic Acid Market Analysis and Outlook To 2032
10.1 Introduction to Asia Pacific Polyglycolic Acid Markets in 2024
10.2 Asia Pacific Polyglycolic Acid Market Size Outlook by Country, 2021-2032
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Polyglycolic Acid Market size Outlook by Segments, 2021-2032
By Form
Fibers
Films
Others
By End-User
Medical
Oil & Gas
Packaging
Others
11 South America Polyglycolic Acid Market Analysis and Outlook To 2032
11.1 Introduction to South America Polyglycolic Acid Markets in 2024
11.2 South America Polyglycolic Acid Market Size Outlook by Country, 2021-2032
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Polyglycolic Acid Market size Outlook by Segments, 2021-2032
By Form
Fibers
Films
Others
By End-User
Medical
Oil & Gas
Packaging
Others
12 Middle East and Africa Polyglycolic Acid Market Analysis and Outlook To 2032
12.1 Introduction to Middle East and Africa Polyglycolic Acid Markets in 2024
12.2 Middle East and Africa Polyglycolic Acid Market Size Outlook by Country, 2021-2032
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Polyglycolic Acid Market size Outlook by Segments, 2021-2032
By Form
Fibers
Films
Others
By End-User
Medical
Oil & Gas
Packaging
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
Advanced Medical Solutions Group PLC
BASF SE
BMG Inc
Boen Healthcare Co. Ltd
China Petrochemical Corp
Danhua Chemical Technology Co. Ltd
DuPont de Nemours Inc
Evonik Industries AG
Hitachi Ltd
Huizhou Foryou Medical Devices Co. Ltd
Kureha Corp
Merck Group
Meta Biomed Co. Ltd
Orion Sutures India Pvt. Ltd
Samyang Biopharm Corp
Shanghai Pujing Chemical Technology Co. Ltd
Shenzhen Polymtek Biomaterial Co. Ltd
SK Chemicals Co. Ltd
Teleflex Inc
The Chemours Company
Toray Industries Inc
Unisur Lifecare Pvt. Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Form
Fibers
Films
Others
By End-User
Medical
Oil & Gas
Packaging
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Polyglycolic Acid Market Size is valued at $5.3 Billion in 2024 and is forecast to register a growth rate (CAGR) of 8.3% to reach $10 Billion by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Advanced Medical Solutions Group PLC, BASF SE, BMG Inc, Boen Healthcare Co. Ltd, China Petrochemical Corp, Danhua Chemical Technology Co. Ltd, DuPont de Nemours Inc, Evonik Industries AG, Hitachi Ltd, Huizhou Foryou Medical Devices Co. Ltd, Kureha Corp, Merck Group, Meta Biomed Co. Ltd, Orion Sutures India Pvt. Ltd, Samyang Biopharm Corp, Shanghai Pujing Chemical Technology Co. Ltd, Shenzhen Polymtek Biomaterial Co. Ltd, SK Chemicals Co. Ltd, Teleflex Inc, The Chemours Company, Toray Industries Inc, Unisur Lifecare Pvt. Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume